Ontology highlight
ABSTRACT: Objectives
Few studies have reported clinical COVID-19 sequelae six months (M6) after hospital discharge, but none has studied symptom severity.Methods
Prevalence and severity of 7 symptoms were estimated until M6 using the self-administered influenza severity scale in COVID-19 hospitalized patients enrolled in the French COVID cohort. Factors associated with severity were assessed by logistic regression. Anxiety, depression and health-related quality of life (HRQL) were also assessed.Results
At M6, among the 324 patients (median age 61 years, 63% men, 19% admitted to intensive care during the acute phase), 187/324 (58%) reported at least one symptom, mostly fatigue (47%) and myalgia (23%). Symptom severity was scored, at most, mild in 125 (67%), moderate in 44 (23%) and severe in 18 (10%). Female gender was the sole factor associated with moderate/severe symptom reporting (OR = 1.98, 95%CI=1.13-3.47). Among the 225 patients with psychological assessment, 24 (11%) had anxiety, 18 (8%) depressive symptoms, and their physical HRQL was significantly poorer than the general population (p=0.0005).Conclusion
Even if 58% of patients reported ≥1 symptom at M6, less than 7% rated any symptom as severe. Assessing symptoms severity could be helpful to identify patients requiring appropriate medical care. Women may require special attention.
SUBMITTER: Eloy P
PROVIDER: S-EPMC8432979 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature
Eloy Philippine P Tardivon Coralie C Martin-Blondel Guillaume G Isnard Margaux M Turnier Paul LE PL Marechal Marion LE ML Cabié André A Launay Odile O Tattevin Pierre P Senneville Eric E Ansart Séverine S Goehringer François F Chirouze Catherine C Bousson Laurane L Laouénan Cédric C Etienne Manuel M Nguyen Duc D Ghosn Jade J Duval Xavier X
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20210911
<h4>Objectives</h4>Few studies have reported clinical COVID-19 sequelae six months (M6) after hospital discharge, but none has studied symptom severity.<h4>Methods</h4>Prevalence and severity of 7 symptoms were estimated until M6 using the self-administered influenza severity scale in COVID-19 hospitalized patients enrolled in the French COVID cohort. Factors associated with severity were assessed by logistic regression. Anxiety, depression and health-related quality of life (HRQL) were also ass ...[more]